Scancell Limited - Company & Market Research Reports

Scancell was founded in 1996 and is headquartered in Nottingham, United Kingdom. Scancell main 2 cancer vaccine programmes are ImmunoBody® and Moditope®. Scancells first vaccine SCIB1 is showing positive results for patients in resected Stage II or III disease, it is used to treat melanoma. Scancell Limited operates as a subsidiary of Scancell Holdings PLC.

Competitor Analysis: Cancer Vaccines - Product Thumbnail Image

Competitor Analysis: Cancer Vaccines

  • Report
  • 179 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Melanocyte Protein PMEL - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanocyte Protein PMEL - Pipeline Review, H1 2018

  • Drug Pipelines
  • 53 Pages
From
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016 - Product Thumbnail Image

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 68 Pages
From
Esophageal Cancer - Pipeline Review, H2 2018 - Product Thumbnail Image

Esophageal Cancer - Pipeline Review, H2 2018

  • Drug Pipelines
  • 779 Pages
From
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2018 - Product Thumbnail Image

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 74 Pages
From
Osteosarcoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 498 Pages
From
Gastric Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Gastric Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1283 Pages
From
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H1 2018 - Product Thumbnail Image

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 77 Pages
From
Osteosarcoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Osteosarcoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 421 Pages
From
New Trends in Preventive and Therapeutic Vaccines - Product Thumbnail Image

New Trends in Preventive and Therapeutic Vaccines

  • Report
From
Apoptosis - Global Strategic Business Report - Product Thumbnail Image

Apoptosis - Global Strategic Business Report

  • Report
  • 617 Pages
From
Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016 - Product Thumbnail Image

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 79 Pages
From
Ovarian Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2412 Pages
From
Pancreatic Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2509 Pages
From
Colorectal Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Colorectal Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2237 Pages
From
Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1759 Pages
From
Melanoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Melanoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 2011 Pages
From
Non-Small Cell Lung Cancer - Pipeline Review, H1 2018 - Product Thumbnail Image

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • Drug Pipelines
  • 3034 Pages
From
Metastatic Melanoma - Pipeline Review, H2 2016 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Review, H2 2016

  • Drug Pipelines
  • 648 Pages
From
Loading Indicator
adroll